PADI4 and rheumatoid arthritis: Additionally, mitigation of disease severity due to PAD4 deficiency or by treatment with PAD inhibitors was reported in mouse models of RA [123,124], hypoxic ischemic insult in neonates [125], cardiac dysfunction [126] and neurodegenerative disorders [120].